Glynn S - Search Results

1

Proteomic analysis of isolated membrane fractions from superinvasive cancer cells.

Dowling P, Meleady P, Dowd A, Henry M, Glynn S, Clynes M. Dowling P, et al. Among authors: glynn s. Biochim Biophys Acta. 2007 Jan;1774(1):93-101. doi: 10.1016/j.bbapap.2006.09.014. Epub 2006 Sep 30. Biochim Biophys Acta. 2007. PMID: 17085086

2

Purification and identification of a 7.6-kDa protein in media conditioned by superinvasive cancer cells.

Dowling P, Maurya P, Meleady P, Glynn SA, Dowd AJ, Henry M, Clynes M. Dowling P, et al. Among authors: glynn sa. Anticancer Res. 2007 May-Jun;27(3A):1309-17. Anticancer Res. 2007. PMID: 17593624 Free article.

3

Low adhesiveness coupled with high superinvasiveness in vitro predicts the in vivo metastatic potential of a mouse mammary adenocarcinoma cell line.

Glynn SA, Adams A, Gibson B, Cronin D, Harmey JH, Clynes M. Glynn SA, et al. Anticancer Res. 2006 Mar-Apr;26(2A):1001-10. Anticancer Res. 2006. PMID: 16619499 Free article.

4

A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin.

Glynn SA, Gammell P, Heenan M, O'Connor R, Liang Y, Keenan J, Clynes M. Glynn SA, et al. Br J Cancer. 2004 Nov 15;91(10):1800-7. doi: 10.1038/sj.bjc.6602221. Br J Cancer. 2004. PMID: 15505620 Free PMC article.

5

The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.

Glynn SA, O'Sullivan D, Eustace AJ, Clynes M, O'Donovan N. Glynn SA, et al. BMC Cancer. 2008 Jan 16;8:9. doi: 10.1186/1471-2407-8-9. BMC Cancer. 2008. PMID: 18199328 Free PMC article.

6

Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.

O'Driscoll L, Linehan R, M Kennedy S, Cronin D, Purcell R, Glynn S, W McDermott E, D Hill A, J O'Higgins N, Parkinson M, Clynes M. O'Driscoll L, et al. Among authors: glynn s. Cancer Lett. 2003 Nov 25;201(2):225-36. doi: 10.1016/s0304-3835(03)00518-4. Cancer Lett. 2003. PMID: 14607338

7

Expression and prognostic relevance of Mcl-1 in breast cancer.

O'Driscoll L, Cronin D, Kennedy SM, Purcell R, Linehan R, Glynn S, Larkin A, Scanlon K, McDermott EW, Hill AD, O'Higgins NJ, Parkinson M, Clynes M. O'Driscoll L, et al. Among authors: glynn s. Anticancer Res. 2004 Mar-Apr;24(2A):473-82. Anticancer Res. 2004. PMID: 15152946 Free article.

8

Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

Cheng RY, Basudhar D, Ridnour LA, Heinecke JL, Kesarwala AH, Glynn S, Switzer CH, Ambs S, Miranda KM, Wink DA. Cheng RY, et al. Among authors: glynn s. Nitric Oxide. 2014 Dec 1;43:17-28. doi: 10.1016/j.niox.2014.08.003. Epub 2014 Aug 19. Nitric Oxide. 2014. PMID: 25153034 Free PMC article. Review.

9

The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance.

Toner AP, McLaughlin F, Giles FJ, Sullivan FJ, O'Connell E, Carleton LA, Breen L, Dunne G, Gorman AM, Lewis JD, Glynn SA. Toner AP, et al. Among authors: glynn sa. Br J Cancer. 2013 Oct 15;109(8):2131-41. doi: 10.1038/bjc.2013.537. Epub 2013 Sep 19. Br J Cancer. 2013. PMID: 24052043 Free PMC article.

10

Sensitivity Profiles of Human Prostate Cancer Cell Lines to an 80 Kinase Inhibitor Panel.

Burke AJ, Ali H, O'Connell E, Sullivan FJ, Glynn SA. Burke AJ, et al. Anticancer Res. 2016 Feb;36(2):633-41. Anticancer Res. 2016. PMID: 26851018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters